Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin (Q41901294)

13 October 2017

title

Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin (English)

1 reference

13 October 2017

0 references

G M Berger

1

1 reference

13 October 2017

A D Marais

2

1 reference

13 October 2017

H C Seftel

3

1 reference

13 October 2017

S G Baker

4

1 reference

13 October 2017

D Mendelsohn

5

1 reference

13 October 2017

N H Welsh

6

1 reference

13 October 2017

B I Joffe

7

1 reference

13 October 2017

publication date

1 April 1989

1 reference

Cardiovascular Drugs and Therapy

13 October 2017

published in

1 reference

13 October 2017

volume

3

1 reference

13 October 2017

issue

2

1 reference

13 October 2017

page(s)

219-227

1 reference

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

13 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01883868

Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01883868

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol

1 reference

12 December 2020

Therapeutic effects of ML-236B in primary hypercholesterolemia

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia

1 reference

12 December 2020

Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia

1 reference

12 December 2020

Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase

1 reference

12 December 2020

Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia

1 reference

12 December 2020

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

1 reference

12 December 2020

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

12 December 2020

Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin

1 reference

12 December 2020

Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

1 reference

12 December 2020

Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum

1 reference

12 December 2020

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

12 December 2020

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

12 December 2020

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity

1 reference

12 December 2020

Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia

1 reference

12 December 2020

Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase

1 reference

12 December 2020

The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects

1 reference

12 December 2020

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth

1 reference

12 December 2020

Lowering Plasma Cholesterol by Raising LDL Receptors

1 reference

12 December 2020

Synthesis of ubiquinone and cholesterol in human fibroblasts: Regulation of a branched pathway

1 reference

12 December 2020

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia

1 reference

12 December 2020

Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

More on rifampin prophylaxis against Haemophilus influenzae b in day-care facilities

1 reference

12 December 2020

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

12 December 2020

Probucol versus eptastatin in hypercholesterolaemic diabetics

1 reference

12 December 2020

Lovastatin: follow-up ophthalmologic data

1 reference

12 December 2020

Comparison of six pharmacologic regimens for hypercholesterolemia

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

1 reference

12 December 2020

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

12 December 2020

Adverse effects of hypolipidaemic drugs.

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia

1 reference

12 December 2020

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia

1 reference

12 December 2020

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase

1 reference

12 December 2020

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

1 reference

12 December 2020

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

1 reference

12 December 2020

Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01883868

1 reference

release_vr2p3yjxmngyxarlmoxcl4tu64

13 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vr2p3yjxmngyxarlmoxcl4tu64

24 November 2022

mapped directly with Wikidata item

1 reference